Jason Kelly
Vermogen: 22 M $ op 31-05-2026
Vermogen: 22 M $ op 31-05-2026
Jason Kelly richtte Ginkgo Bioworks Holdings, Inc. en Ginkgo Bioworks, Inc. op. Momenteel bekleedt hij de functie van Chief Executive Officer & Director bij Ginkgo Bioworks Holdings, Inc. en Chief Executive Officer & Director bij Ginkgo Bioworks, Inc. (een dochteronderneming van Ginkgo Bioworks Holdings, Inc.). Dr. Kelly zit ook in de raad van bestuur van Octant, Inc. en Motif Food Works, Inc. In zijn vorige loopbaan was Dr. Kelly Chief Executive Officer & Director bij Soaring Eagle Acquisition Corp. Hij behaalde een bachelor en een doctoraat aan het Massachusetts Institute of Technology.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2026 | 2.041.437 ( 22,21% ) | 19 M $ | 31-05-2026 | |
| 15-04-2026 | 316.483 ( 0,59% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Oprichter | 01-01-2008 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Oprichter | 01-01-2008 |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Directeur/Bestuurslid | - |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Bestuurslid | - |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Directeur/Bestuurslid | - |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Private Equity Investor | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| STANDARD BIOTOOLS INC. | Directeur/Bestuurslid | 01-09-2021 |
| GINO BIOW | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 9 |
|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Develops synthetic biology technologies | Health Technology |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
NextGen Venture Partners LLC
NextGen Venture Partners LLC Investment ManagersFinance NextGen Venture Partners invests in companies located in the United States with a minimum revenues of USD 10 million. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 0.5 - 2 million for seed and early stage companies and USD 3 - 5 million for growth stage companies. | Finance |
Motif Food Works, Inc.
Motif Food Works, Inc. Food: Major DiversifiedConsumer Non-Durables Operates as a food ingredients company which provides sustainable alternative proteins and ingredient solutions | Consumer Non-Durables |
CM Life Sciences II, Inc.
CM Life Sciences II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau